Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia

1993 ◽  
Vol 39 (4) ◽  
pp. 333-339 ◽  
Author(s):  
Kenichi Umene ◽  
Tadasu Nunoue
2011 ◽  
Vol 106 (4) ◽  
pp. 502-504 ◽  
Author(s):  
Marcos César Lima de Mendonça ◽  
Ana Maria de Amorim Ferreira ◽  
Marta Gonçalves Matos dos Santos ◽  
Elva Cristina Oviedo ◽  
Maria Sônia Dal Bello ◽  
...  

2017 ◽  
Vol 63 (3) ◽  
pp. 224-228 ◽  
Author(s):  
Maria Isabel de Oliveira ◽  
Ana Maria Sardinha Afonso ◽  
Suely Pires Curti ◽  
Patrícia Evelin Silva ◽  
Tamyris Fernanda Barbosa ◽  
...  

Summary Introduction: Virus surveillance strategies and genetic characterization of human parvovirus B19 (B19V) are important tools for regional and global control of viral outbreak. In São Paulo, Brazil, we performed a study of B19V by monitoring the spread of this virus, which is an infectious agent and could be mistakenly reported as a rash and other types of infection. Method: Serum samples were subjected to enzyme immunoassay, real time polymerase chain reaction, and sequencing. Results: From the 462 patients with suspected cases of exanthematic infections, the results of the 164 serum samples were positive for B19V immunoglobulin M. Among these cases, there were 38 patients with erythema infections and B19-associated with other infections such as encephalitis, hydrops fetalis, chronic anemia, hematological malignancies. These samples were sequenced and identified as genotype 1. Conclusion: This study showed patients with infections caused by B19V and sequencing genotype 1. Continuous monitoring is necessary to detect all known genotypes, and the emergence of new genotypes of these viruses for case management in public health control activities.


2014 ◽  
Vol 87 (2) ◽  
pp. 303-309 ◽  
Author(s):  
Parul Jain ◽  
Amita Jain ◽  
Shantanu Prakash ◽  
Danish N Khan ◽  
Desh D Singh ◽  
...  

2015 ◽  
Vol 42 (4) ◽  
pp. 233-238 ◽  
Author(s):  
Xavier Bonjoch ◽  
Francesc Obispo ◽  
Cristina Alemany ◽  
Ana Pacha ◽  
Esteban Rodríguez ◽  
...  

1989 ◽  
Vol 33 (7) ◽  
pp. 561-567 ◽  
Author(s):  
Nobuo Yaegashi ◽  
Kohtaro Tada ◽  
Hiroyuki Shiraishi ◽  
Takehisa Ishii ◽  
Kinnya Nagata ◽  
...  

2015 ◽  
Vol 201 ◽  
pp. 1-7 ◽  
Author(s):  
José Sebastián Santillán-Uribe ◽  
Josefina Valadez-García ◽  
Areli del Carmen Morán-García ◽  
Hugo César Santillán-Uribe ◽  
Ismael Bustos-Jaimes

2015 ◽  
Vol 88 (6) ◽  
pp. 947-953 ◽  
Author(s):  
Farhad Rezaei ◽  
Behrang Sarshari ◽  
Nastaran Ghavami ◽  
Parisa Meysami ◽  
Azadeh Shadab ◽  
...  

2010 ◽  
Vol 84 (19) ◽  
pp. 9658-9665 ◽  
Author(s):  
Annabelle Servant-Delmas ◽  
Jean-Jacques Lefrère ◽  
Frédéric Morinet ◽  
Sylvie Pillet

ABSTRACT Since its discovery, human parvovirus B19 (B19V), now termed erythrovirus, has been associated with many clinical situations (neurological and myocardium infections, persistent B19V DNAemia) in addition to the prototype clinical manifestations, i.e., erythema infectiosum and erythroblastopenia crisis. In 2002, the use of new molecular tools led to the characterization of three different genotypes of human B19 erythrovirus. Although the genomic organization is conserved, the geographic distribution of the different genotypes varies worldwide, and the nucleotidic divergences can impact the molecular diagnosis of B19 virus infection. The cell cycle of the virus remains partially unresolved; however, recent studies have shed light on the mechanism of cell entry and the interactions of B19V proteins with apoptosis pathways.


Sign in / Sign up

Export Citation Format

Share Document